Founded in 2012 in Germany, TVM Capital Life Science focuses on investing in entrepreneurial venture-backed companies in the life science sector. With offices in Montreal, Canada and Munich, Germany, the firm follows a multi-stage investment approach, supporting companies from discovery to market-ready stages. Their investment focus includes therapeutics, technology platforms, medtech, and diagnostics. TVM Capital Life Science has a preference for startups aged 11-15 years and has invested in notable companies such as Emovi, Acer Therapeutics, and CoLucid Pharmaceuticals. While the firm's foundation is in Germany, it primarily invests in the United States, Canada, and Western Europe.